Transcode Therapeutics Inc (RNAZ)

Nov 22, 2025

TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - MSN

Nov 22, 2025

Nov 20, 2025

Is TransCode Therapeutics Inc. stock a contrarian buyRecession Risk & Technical Pattern Recognition Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

TransCode Therapeutics, Inc. (RNAZ) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 20, 2025

Nov 20, 2025

MSN Money - MSN

Nov 20, 2025

Nov 19, 2025

Real time breakdown of TransCode Therapeutics Inc. stock performanceEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What technical models suggest about TransCode Therapeutics Inc.’s comeback2025 Dividend Review & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can TransCode Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com

Nov 19, 2025

Nov 19, 2025

Is TransCode Therapeutics Inc. stock resilient to inflationMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

TransCode Therapeutics Inc. recovery potential after sell offQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Will TransCode Therapeutics Inc. stock outperform value stocks2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025

Nov 18, 2025

Why retail investors favor TransCode Therapeutics Inc. stockWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

Nov 18, 2025

Nov 18, 2025

Market reaction to TransCode Therapeutics Inc.’s recent news - newser.com

Nov 18, 2025

Nov 17, 2025

TransCode Therapeutics appoints Michel Janicot as development officer By Investing.com - Investing.com Nigeria

Nov 17, 2025

Nov 17, 2025

TransCode Therapeutics Appoints Dr. Michel Janicot as Senior Development Officer - citybiz

Nov 17, 2025

Nov 17, 2025

TransCode Therapeutics appoints Michel Janicot as development officer - Investing.com India

Nov 17, 2025

Nov 17, 2025

Transcode Therapeutics expands executive team with appointment of Dr. Michel Janicot as Senior Development Officer - MarketScreener

Nov 17, 2025

Nov 17, 2025

Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer - TradingView

Nov 17, 2025

Nov 17, 2025

TransCode Appoints Dr. Michel Janicot Senior Development Officer | RNAZ Stock News - Stock Titan

Nov 17, 2025

Nov 16, 2025

Is a relief rally coming for TransCode Therapeutics Inc. holders2025 Earnings Surprises & Capital Efficiency Focused Strategies - newser.com

Nov 16, 2025

Nov 14, 2025

Goldman Sachs Group Inc Significantly Reduces Holdings in TransCode Therapeutics Inc - GuruFocus

Nov 14, 2025

Nov 14, 2025

TransCode Therapeutics Inc. (RNAZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 14, 2025

Nov 14, 2025

TransCode Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 14, 2025

Nov 14, 2025

Using Python tools to backtest TransCode Therapeutics Inc. strategies2025 Retail Activity & Real-Time Volume Triggers - newser.com

Nov 14, 2025